Novel CRISPR/Cas12a-based genetic diagnostic approach for SLC26A4 mutation-related hereditary hearing loss-Reference-Cited by-同舟云学术

Novel CRISPR/Cas12a-based genetic diagnostic approach for SLC26A4 mutation-related hereditary hearing loss

Published:2022-02 Issue:2 Volume:65 Page:104406
ISSN:1769-7212
Container-title:European Journal of Medical Genetics
language:en
Short-container-title:European Journal of Medical Genetics

Author:

Jin Xiaohua,Zhang Lu^ORCID,Wang Xinjie,An Lisha,Huang Shasha,Dai Pu,Gao Huafang,Ma Xu

Funder

National Key Research and Development Program of China

Publisher

Elsevier BV

Subject

Genetics (clinical),Genetics,General Medicine

Reference33 articles.

1. Rapid molecular detection of Zika virus in acute-phase urine samples using the recombinase polymerase amplification assay;Abd El Wahed;PLoS Curr,2017

2. Nucleic acid detection of plant genes using CRISPR-cas13;Abudayyeh;CRISPR J,2019

3. CRISPR-based rapid and ultra-sensitive diagnostic test for Mycobacterium tuberculosis;Ai;Emerg. Microb. Infect.,2019

4. SLC26A4 mutation spectrum associated with DFNB4 deafness and Pendred's syndrome in Pakistanis;Anwar;J. Hum. Genet.,2009

5. A novel missense mutation in GIPC3 causes sensorineural hearing loss in an Iranian family revealed by targeted next-generation sequencing;Asgharzade;Int. J. Pediatr. Otorhinolaryngol.,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of the inner ear and regeneration of hair cells after hearing impairment;Fundamental Research;2023-11

2. In Vitro CRISPR-Cas12a-Based Detection of Cancer-Associated TP53 Hotspot Mutations Beyond the crRNA Seed Region;The CRISPR Journal;2023-04-01

3. Integrating CRISPR/Cas within isothermal amplification for point-of-Care Assay of nucleic acid;Talanta;2022-06